J&J's Orthopedics Spin-Off: A New Chapter?

Johnson & Johnson just dropped a bombshell! They're spinning off their $9 billion orthopedics division, DePuy Synthes, to zero in on their pharma and MedTech powerhouses. Get the scoop on why they're betting big on prescription drugs, surgical tech, and more, plus what it means for investors after a surprising stock dip despite strong earnings. Is this the key to unlocking even bigger growth for J&J?The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.